Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin to Skin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00512902
What this trial is testing

A Study Using The Experimental Drug Called Imatinib (Gleevec) in Subjects With Systemic Sclerosis

Who this might be right for
AlveolitisSystemic Sclerosis
University of California, Los Angeles 20
Early research (Phase 1)Active Not RecruitingNCT02159495
What this trial is testing

Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAcute Biphenotypic LeukemiaEarly Relapse of Acute Myeloid Leukemia+10 more
City of Hope Medical Center 31
Testing effectiveness (Phase 2)UnknownNCT05134519
What this trial is testing

RC48 for Neoadjuvant Chemotherapy of HER2 Positive Breast Cancer

Who this might be right for
Breast CancerHER2-positive Breast Cancer
Xijing Hospital 20
Not applicableStudy completedNCT03332628
What this trial is testing

Racial/Ethnic Differences in Microneedle Response

Who this might be right for
Healthy
University of Iowa 132
Testing effectiveness (Phase 2)Study completedNCT00988936
What this trial is testing

Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug

Who this might be right for
Metastatic Breast CancerMetastatic Colon/Rectum CancerNon-squamous Non-small Cell Lung Cancer
Siemens Molecular Imaging 35
Not applicableNot Yet RecruitingNCT07553234
What this trial is testing

Study to Understand Relationship Between Gut Health and Toxicities of Hormonal Breast Cancer Treatment

Who this might be right for
Breast Cancer
University of Chicago 20
Early research (Phase 1)UnknownNCT04357509
What this trial is testing

The Tolerance,Pharmacokinetic Characteristics,Safety and Efficacy of ScTIL210 in the Treatment of Melanoma

Who this might be right for
Melanoma
Peking University Cancer Hospital & Institute 32
Post-approval studies (Phase 4)Not Yet RecruitingNCT07093931
What this trial is testing

Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer

Who this might be right for
Breast Cancer
Shandong Cancer Hospital and Institute 468
Large-scale testing (Phase 3)Study completedNCT02490631
What this trial is testing

2% Chlorhexidine Gluconate Skin Cloths to Prevent SSI in Spine Surgery Patients

Who this might be right for
Surgical Site InfectionsPost Operative Complication
Vanderbilt University 158
Not applicableStudy completedNCT05619237
What this trial is testing

Pivotal Study of an Antimicrobial Wound Dressing to Treat Chronic Wounds

Who this might be right for
Pressure InjuryVenous Leg UlcerPressure Injury Stage 2+4 more
Chester Ho, MD 44
Not applicableNot Yet RecruitingNCT07799467
What this trial is testing

Implementing a Digital Alcohol Intervention to Raise Women's Awareness of Alcohol-related Breast Cancer Risk During Routine Screening Visits

Who this might be right for
Breast CancerAlcohol Drinking
University of Miami 36
Not applicableStudy completedNCT01221207
What this trial is testing

Instant Total Contact Cast to Heal Diabetic Foot Ulcers

Who this might be right for
Diabetic Foot Ulcers
University of Texas Southwestern Medical Center 225
Not applicableStudy completedNCT02191007
What this trial is testing

Efficacy and Safety Study of Calcipotriol Betamethasone Plus Calcipotriol in Sequential Therapy to Psoriasis

Who this might be right for
Psoriasis
Xijing Hospital 230
Not applicableStudy completedNCT03277131
What this trial is testing

DURAFIBER Ag Post-Market Clinical Follow-Up

Who this might be right for
Wounds and InjuriesVenous Leg UlcerInfection
Smith & Nephew, Inc. 20
Large-scale testing (Phase 3)Ended earlyNCT00082095
What this trial is testing

To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older

Who this might be right for
Metastatic Breast Cancer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 62
Not applicableEnded earlyNCT06572839
What this trial is testing

Amnio-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone

Who this might be right for
Diabetic Foot Ulcer
Capsicure, LLC 74
Early research (Phase 1)Looking for participantsNCT04842812
What this trial is testing

Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors

Who this might be right for
Liver CancerLung CancerBreast Cancer+5 more
Second Affiliated Hospital of Guangzhou Medical University 40
Early research (Phase 1)Study completedNCT01605630
What this trial is testing

Family Cancer Literacy to Promote Mammography Screening Among Navajo Women

Who this might be right for
Breast Cancer
Mayo Clinic 40
Large-scale testing (Phase 3)Study completedNCT00975130
What this trial is testing

Subcutaneous Golimumab (GLM) Plus DMARDs for Rheumatoid Arthritis, Followed by Intravenous/Subcutaneous GLM Strategy (P06129 AM2)

Who this might be right for
Arthritis, Rheumatoid
Merck Sharp & Dohme LLC 3,366
Large-scale testing (Phase 3)Study completedNCT04976192
What this trial is testing

Study to Compare Efficacy and Safety of TEV-45779 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria

Who this might be right for
Chronic Urticaria
Teva Pharmaceuticals USA 608
Next Page